News

10

Feb, 2022

Save the date! Penta aperitivo webinar 17 Feb 2022

 

The Penta Aperitivo webinars are here to keep you up to date with the latest Penta activities and on the new developments on the prevention, diagnosis, and treatment of infectious diseases in children. The next webinar with top experts from our Network will focus on pediatric ARV trials and on the treatment of congenital CMV.   Date: Thursday, 17 February 2022 Time: 19:00 – 20:00 CET (Italy time) // 18:00-19:00 (UK time) Chairs: Di Gibb, MRC Clinical Trials Unit at UCL, UK Pauline Amuge, Baylor College of Medicine Children’s Foundation, Uganda   Agenda: What is new in Penta […]

READ MORE

8

Feb, 2022

PediCAP microbiology sub-study sites receive training from LAB-NET

Tags:

At the end of 2021, LAB-Net provided training on the sampling and microbiology procedures to all five sites taking part in the microbiology sub-study in the Paediatric Community Acquired Pneumonia (PediCAP) project.   Microbiologists, technicians and study investigators from local teams in South Africa, Uganda, Zambia and Zimbabwe attended online training sessions conducted in November and December. Before the training, LAB-Net developed a sample collection and management manual and sampling instructions for the sites. The local study teams were provided with sample kits prepared and shipped by the central laboratory at […]

READ MORE

27

Jan, 2022

Science4Pandemics: A European Gamification Project to Better Prepare Young People for Future Pandemics

Tags:

The digital platform will educate young people and provide real-world data for collaborative research on pandemics.   Barcelona, 27 January 2022. Despite the many advances in the global fight against infectious diseases and the millions of lives saved by vaccines and other preventive and therapeutic methods, infections remain a major threat to humanity. COVID-19 has remined us of the devastating effects that pandemics can have globally. Beyond the clear prominence of SARS-CoV-2, however, malaria, tuberculosis, HIV/AIDS and multidrug-resistant bacteria remain major causes of morbidity and mortality. Last week saw the […]

READ MORE

25

Jan, 2022

COVID-19 vaccines for children, adolescents and immunocompromised patients

Tags:

Penta is proud to be a partner in the Horizon Europe funded “RBD Dimer recombinant protein vaccine against SARSCoV2” (RBDCOV) project. Within the project we will be bringing our paediatric expertise and drive to improve health outcomes for children. During the project’s 2.5-year duration, RBDCOV will test the efficacy, tolerability, and safety of the Covid-19 vaccine in children, adolescents and immunocompromised people. Read the RBDCOV press release for more on the project.  

READ MORE

30

Dec, 2021

Once-daily DTG more effective in treating HIV in children

Tags: ,

The ODYSSEY trial’s final paper Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children has been published in the New England Journal of Medicine. ODYSSEY, sponsored by Penta and funded by ViiV Healthcare, is the first randomised controlled trial to compare the efficacy and safety of dolutegravir-based regimens to non-dolutegravir-based standard-of-care regimens in children and adolescents. Dolutegravir (DTG) is a drug shown to be highly effective and safe in treating HIV in adults, and ODYSSEY, enrolling more than 700 children from Uganda, South Africa, Zimbabwe, Thailand, UK, Germany, […]

READ MORE

15

Dec, 2021

Ethical youth engagement in the HIV response

Tags: ,

Penta youth in collaboration with IAS, have organised a webinar taking place on Thursday, 16 December at 12pm CET (GMT+1) on the theme Invest in our future: How to walk the talk of ethical Youth engagement in the HIV response. The objectives of the webinar are to showcase best practices for youth participation within the HIV sector, to highlight the current gaps in proactive responses to youth participation models and insight, and to discuss the importance of ethical youth engagement being backed by policies co-produced by young people and key […]

READ MORE

7

Dec, 2021

REACH project published in CORDIS

Tags: ,

We are proud to announce that the REACH project’s Result in Brief article, Reducing infectious disease in mothers and children in Russia, has been uploaded on the CORDIS website. This is a great opportunity to share our work, with the rest of the world and will ensure that our study results, when available, are available to many. None of what REACH has achieved would have been possible without the collaborative effort of our partners in Europe and the Russian Federation. Through the joint commitment of our members, the REACH project […]

READ MORE

1

Dec, 2021

World AIDS Day 2021: How paediatric HIV has changed in the last 30 years

Tags: ,

It takes a community of people working together to achieve the results we are looking for: eradication HIV in children   The paediatric HIV pandemic has changed from when researchers first began investigating HIV in children to where we stand today. The burden of perinatal infections, however, remains high. Perinatal infections occur when a pregnant person living with HIV passes HIV to her baby either during pregnancy, delivery or through breastfeeding. Despite unprecedented advances in the prevention of perinatal infections (including those occurring through breastfeeding) utilizing maternal ART and infant […]

READ MORE
NEWSLETTER

We would like to update you on our recent activities